Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Batoclimab 💬1件: Batoclimab1件: Batoclimab--2件: 11, 14 💬
2 Carmustine 💬1件: Carmustine2件: Carmustina; Carmustine--5件: 11, 13, 14, 28, 60 💬
3 Chlorphenamine 💬1件: Chlorpheniramine0件: 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬-
4 Chlorpheniramine maleate 💬1件: Chlorpheniramine0件: 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬-
5 Cyclophosphamide 💬1件: Cyclophosphamide5件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide monohydrate--46件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 220, 221, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
6 Cyclophosphamide 💬1件: Cyclophosphamide5件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide monohydrate--46件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 220, 221, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
7 Cytarabine 💬1件: Cytarabine2件: Citarabina; Cytarabine--7件: 11, 13, 14, 25, 34, 49, 60 💬
8 Cytarabine hydrochloride 💬1件: Cytarabine2件: Citarabina; Cytarabine--7件: 11, 13, 14, 25, 34, 49, 60 💬
9 Dalfampridine 💬1件: Dalfampridine5件: 4-aminopyridine; 4-AP; Dalfampridine; Fampridina; Fampridine4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬4件: 3, 4, 13, 14 💬
10 Dexamethasone 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
11 Dexamethasone phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
12 Dexamethasone sodium phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
13 Eculizumab 💬1件: Eculizumab1件: Eculizumab1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 222 💬
14 Efgartigimod alfa 💬1件: Efgartigimod alfa1件: Efgartigimod alfa--6件: 11, 14, 35, 53, 63, 162 💬
15 Empasiprubart 💬1件: Empasiprubart1件: Empasiprubart1件: C2 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
16 Etoposide 💬1件: Etoposide1件: Etoposide--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
17 Etoposide phosphate 💬1件: Etoposide1件: Etoposide--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
18 Fibrinogen I 125 💬1件: Fibrinogen human3件: Fibrinogen; Fibrinogen concentrate; Human fibrinogen--3件: 14, 65, 107 💬
19 Fingolimod 💬1件: Fingolimod2件: Fingolimod; Fingolimod hydrochloride1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
20 Fingolimod hydrochloride 💬1件: Fingolimod2件: Fingolimod; Fingolimod hydrochloride1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
21 Fingolimod lauryl sulfate 💬1件: Fingolimod2件: Fingolimod; Fingolimod hydrochloride1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
22 Globulin, immune 💬1件: Human immunoglobulin G6件: Human immunoglobulin G; Human normal immunoglobulin; Immune globulin; Immunoglobulin; Immunoglobulin G; Intravenous immunoglobulin--9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
23 Hyaluronidase 💬1件: Hyaluronidase (human recombinant)2件: Hyaluronidase; Recombinant human hyaluronidase--3件: 14, 28, 65 💬
24 Melphalan 💬1件: Melphalan2件: Melphalan; Melphalan hydrochloride--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
25 Melphalan hydrochloride 💬1件: Melphalan2件: Melphalan; Melphalan hydrochloride--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
26 Methylprednisolone 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
27 Methylprednisolone acetate 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
28 Nipocalimab 💬1件: Nipocalimab1件: Nipocalimab--6件: 11, 14, 46, 49, 53, 61 💬
29 Prednisolone 💬1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬39件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
30 Prednisone 💬1件: Prednisone2件: Prednisona; Prednisone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
31 Riliprubart 💬1件: Riliprubart1件: Riliprubart1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
32 Rituximab 💬1件: Rituximab1件: Rituximab1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
33 Rozanolixizumab 💬1件: Rozanolixizumab2件: Rozanolixizumab; UCB7665--3件: 11, 14, 63 💬
34 Sodium chloride 💬1件: Sodium chloride2件: Natriumchlorid; Sodium chloride--20件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
35 Tetanus toxoid 💬1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)1件: Tetanus toxoid--3件: 13, 14, 46 💬
36 Tetanus toxoid adsorbed 💬1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)1件: Tetanus toxoid--3件: 13, 14, 46 💬
37 Thioctic acid 💬1件: Lipoic acid1件: Lipoic acid--3件: 13, 14, 20 💬